Literature DB >> 19638506

Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries.

Supriya Gupta Mohile1, Ying Xian, William Dale, Susan G Fisher, Miriam Rodin, Gary R Morrow, Alfred Neugut, William Hall.   

Abstract

BACKGROUND: Few studies have evaluated the independent effect of a cancer diagnosis on vulnerability and frailty, which have been associated with adverse health outcomes in older adults.
METHODS: We used data in the 2003 Medicare Current Beneficiary Survey from a nationally representative sample of 12,480 community-dwelling elders. Multivariable logistic regression models were used to evaluate whether cancer was independently associated with vulnerability and frailty. Measures of vulnerability and frailty included disability, geriatric syndromes, self-rated health, and scores on two assessment tools for elderly cancer patients-the Vulnerable Elders Survey-13 (VES-13) and the Balducci frailty criteria. All statistical tests were two-sided.
RESULTS: Diagnosis of a non-skin cancer was reported by 18.8% of the respondents. Compared with respondents without a cancer history, respondents with a personal history of cancer had a statistically significantly higher prevalence of limitations in activities of daily living (31.9% vs 26.9%), limitations in instrumental activities of daily living (49.5% vs 42.3%), geriatric syndromes (60.8% vs 53.9%), low self-rated health (27.4% vs 20.9%), score of 3 or higher on the VES-13 (45.8% vs 39.5%), and satisfying criteria for frailty as defined by Balducci (79.6% vs 73.4%) (P < .001 for all characteristics). After adjustment for confounders, a cancer diagnosis was found to be associated with low self-rated health (adjusted odds ratio [OR] = 1.46, 95% confidence interval [CI] = 1.30 to 1.64; relative risk [RR] = 1.33), limitations in activities of daily living (adjusted OR = 1.19, 95% CI = 1.06 to 1.33; RR = 1.13), limitations in instrumental activities of daily living (adjusted OR = 1.25, 95% CI = 1.13 to 1.38; RR = 1.13), a geriatric syndrome (adjusted OR = 1.27, 95% CI = 1.15 to 1.41; RR = 1.11), VES-13 score of 3 or higher (adjusted OR = 1.26, 95% CI = 1.13 to 1.41; RR = 1.14), and frailty (adjusted OR = 1.46, 95% CI = 1.29 to 1.65; RR = 1.09) as defined by Balducci criteria.
CONCLUSION: Diagnosis of a non-skin cancer was associated with increased levels of having disability, having geriatric syndromes, and meeting criteria for vulnerability and frailty.

Entities:  

Mesh:

Year:  2009        PMID: 19638506      PMCID: PMC3937788          DOI: 10.1093/jnci/djp239

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  49 in total

Review 1.  The geriatric cancer patient: equal benefit from equal treatment.

Authors:  L Balducci
Journal:  Cancer Control       Date:  2001 Mar-Apr       Impact factor: 3.302

Review 2.  Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients.

Authors:  L Repetto; D Comandini; S Mammoliti
Journal:  Crit Rev Oncol Hematol       Date:  2001-02       Impact factor: 6.312

3.  The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community.

Authors:  D Saliba; M Elliott; L Z Rubenstein; D H Solomon; R T Young; C J Kamberg; C Roth; C H MacLean; P G Shekelle; E M Sloss; N S Wenger
Journal:  J Am Geriatr Soc       Date:  2001-12       Impact factor: 5.562

4.  Drug-drug interactions among elderly patients hospitalized for drug toxicity.

Authors:  David N Juurlink; Muhammad Mamdani; Alexander Kopp; Andreas Laupacis; Donald A Redelmeier
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

5.  Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease.

Authors:  A D Federman; A S Adams; D Ross-Degnan; S B Soumerai; J Z Ayanian
Journal:  JAMA       Date:  2001-10-10       Impact factor: 56.272

6.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

Review 7.  Geriatric syndromes and assessment in older cancer patients.

Authors:  A Naeim; D Reuben
Journal:  Oncology (Williston Park)       Date:  2001-12       Impact factor: 2.990

8.  Cognitive impairment and mortality in older primary care patients.

Authors:  T E Stump; C M Callahan; H C Hendrie
Journal:  J Am Geriatr Soc       Date:  2001-07       Impact factor: 5.562

Review 9.  The frailty syndrome: a critical issue in geriatric oncology.

Authors:  Luigi Ferrucci; Jack M Guralnik; Chiara Cavazzini; Stefania Bandinelli; Fulvio Lauretani; Benedetta Bartali; Lazzaro Repetto; Dan L Longo
Journal:  Crit Rev Oncol Hematol       Date:  2003-05       Impact factor: 6.312

Review 10.  A case for geriatric oncology.

Authors:  Lazzaro Repetto; Lodovico Balducci
Journal:  Lancet Oncol       Date:  2002-05       Impact factor: 41.316

View more
  83 in total

1.  Predicting 5- and 10-year survival in older women with early-stage breast cancer: self-rated health and walking ability.

Authors:  Jessica A Eng; Kerri Clough-Gorr; Howard J Cabral; Rebecca A Silliman
Journal:  J Am Geriatr Soc       Date:  2015-04       Impact factor: 5.562

2.  Are endometrial cancer radiotherapy results age related?

Authors:  Á Rovirosa; K S Cortés; C Ascaso; A Glickman; S Valdés; A Herreros; C Camacho; J Sánchez; Y Zhang; Y Li; S Sabater; M Arenas; A Torne
Journal:  Clin Transl Oncol       Date:  2018-04-12       Impact factor: 3.405

3.  Patient-reported versus objectively-measured physical function and mortality risk among cancer survivors.

Authors:  Justin C Brown; Michael O Harhay; Meera N Harhay
Journal:  J Geriatr Oncol       Date:  2016-02-18       Impact factor: 3.599

Review 4.  Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments.

Authors:  Karen M Mustian; Calvin L Cole; Po Ju Lin; Matt Asare; Chunkit Fung; Michelle C Janelsins; Charles S Kamen; Luke J Peppone; Allison Magnuson
Journal:  Semin Oncol Nurs       Date:  2016-10-21       Impact factor: 2.315

5.  Geriatric syndromes and incident disability in older women: results from the women's health initiative observational study.

Authors:  Andrea L Rosso; Charles B Eaton; Robert Wallace; Rachel Gold; Marcia L Stefanick; Judith K Ockene; J David Curb; Yvonne L Michael
Journal:  J Am Geriatr Soc       Date:  2013-03-01       Impact factor: 5.562

Review 6.  Designing exercise clinical trials for older adults with cancer: Recommendations from 2015 Cancer and Aging Research Group NCI U13 Meeting.

Authors:  Deepak Kilari; Enrique Soto-Perez-de-Celis; Supriya Gupta Mohile; Shabbir M H Alibhai; Carolyn J Presley; Tanya M Wildes; Heidi D Klepin; Wendy Demark-Wahnefried; Amina Jatoi; Robert Harrison; Elizabeth Won; Karen M Mustian
Journal:  J Geriatr Oncol       Date:  2016-05-31       Impact factor: 3.599

Review 7.  Interventions to improve the quality of life and survivorship of older adults with cancer: The funding landscape at NIH, ACS and PCORI.

Authors:  Marie Flannery; Supriya Gupta Mohile; William Dale; Neeraj K Arora; Lauren Azar; Erica S Breslau; Harvey Jay Cohen; Efrat Dotan; Basil A Eldadah; Corinne R Leach; Sandra A Mitchell; Julia H Rowland; Arti Hurria
Journal:  J Geriatr Oncol       Date:  2016-07-05       Impact factor: 3.599

Review 8.  Long-term Toxicity of Cancer Treatment in Older Patients.

Authors:  Armin Shahrokni; Abraham J Wu; Jeanne Carter; Stuart M Lichtman
Journal:  Clin Geriatr Med       Date:  2015-10-13       Impact factor: 3.076

9.  Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study.

Authors:  J S Gewandter; L Fan; A Magnuson; K Mustian; L Peppone; C Heckler; J Hopkins; M Tejani; G R Morrow; S G Mohile
Journal:  Support Care Cancer       Date:  2013-02-28       Impact factor: 3.603

10.  Is the lack of evidence in older adults with cancer compromising safety?

Authors:  Darryl Outlaw; Grant R Williams
Journal:  Expert Opin Drug Saf       Date:  2020-08-05       Impact factor: 4.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.